Stroke News

Among patients with established atherosclerotic heart disease on dialysis, the effect of statins on CV events was modest at best, according to a study published in the American Heart Journal.

High LDL in older patients may confer increased risk for atherosclerotic CVD and MI, and therefore this population may benefit from targeted LDL-lowering therapies, according to two studies published in The Lancet.

Among Black patients with lupus, the risk for stroke is three times higher than white patients, and the risk for ischemic heart disease is 24 times higher, according to a presenter at ACR Convergence 2020 virtual meeting.

AstraZeneca announced the FDA approved its P2Y12 inhibitor ticagrelor for the reduction of stroke risk among patients with acute ischemic stroke or high-risk transient ischemic attack.

A large proportion of young adults in the United States may not be aware of stroke symptoms, according to study results published in Stroke.

Noncommunicable neurological disorders resulted in “a large and increasing burden” in the United States, according to a systematic analysis of the Global Burden of Disease study from 2017 that was published in JAMA Neurology.

Fluctuations in nighttime BP may represent a key predictor of future stroke, CAD and HF, according to a study published in Circulation.

High intake of proinflammatory foods such as red or processed meats and refined carbohydrates was associated with a 38% increased risk for CVD and a poor lipid profile, researchers reported.

The American Heart Association, in collaboration with the Society of Vascular and Interventional Neurology and John Wiley & Sons, announced the launch of a new open-access journal, Stroke: Vascular and Interventional Neurology.

An LPA genetic risk score with 43 single nucleotide variants provided similar risk prediction for atherosclerotic CVD compared with measuring lipoprotein(a), researchers found.